My investable universe of 50 high-quality dividend growth stocks aims to identify attractive opportunities based on valuation and future return potential. Currently, 20 stocks offer an estimated future return of at least 10%, with 10 of these also appearing potentially undervalued by my Free Cash Flow model. Top highlighted stocks like MKTX, RACE, RMD, MSCI, and TTC combine strong free cash flo...
The healthcare sector has experienced a 0.79% decline year-to-date, making it the worst performer among the S&P 500's 11 sectors and the only one in negative territory. But unlike other market-lagging sectors that have performed better of late (e.g.
HCA Healthcare is the best-managed U.S. hospital chain, offering essential services and resilient financials, making it a strong buy for diversified portfolios. Recent results show robust revenue and EPS growth, with aggressive share repurchases and manageable debt supporting shareholder returns. Valuation is attractive: a 16x multiple on 2025 EPS yields a $416 fair value, implying a 25% total ...
HCA Healthcare raised its 2025 profit forecast on Friday as it expects sustained demand for medical procedures to cushion a hit from U.S. President Donald Trump's potential tariffs.
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the second quarter ended June 30, 2025. Key second quarter metrics (all percentage changes compare 2Q 2025 to 2Q 2024 unless otherwise noted): Revenues increased 6.4 percent to $18.605 billion Net income attributable to HCA Healthcare, Inc. increased 13.1 percent to $1.653 bil...
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA), one of the nation's leading healthcare providers, today announced that its board of directors has appointed John W. Chidsey, III as an independent director, effective July 15, 2025. With his addition, HCA Healthcare's board of directors increases from nine to ten members. Mr. Chidsey will serve as a member of HCA Healthcare's ...
I track 50 high-quality dividend growth stocks to identify opportune investments, updating valuation ratings daily to focus on attractive opportunities. In this turbulent year, my investable universe kept up with SPY and outperformed SCHD year-to-date, with a gain of 5.63% compared to 5.72% and -2.13%. This month, 18 stocks had valuation rating changes; 5 were upgrades, including Paychex with a...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.